tradingkey.logo

KORU Medical Systems Inc

KRMD
查看详细走势图
6.230USD
-0.250-3.86%
收盘 12/26, 16:00美东报价延迟15分钟
288.41M总市值
亏损市盈率 TTM

KORU Medical Systems Inc

6.230
-0.250-3.86%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.86%

5天

+7.41%

1月

+7.41%

6月

+71.63%

今年开始到现在

+61.82%

1年

+58.12%

查看详细走势图

TradingKey KORU Medical Systems Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

KORU Medical Systems Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名49/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价5.65。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

KORU Medical Systems Inc评分

相关信息

行业排名
49 / 207
全市场排名
150 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 5 位分析师
买入
评级
5.650
目标均价
-1.40%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

KORU Medical Systems Inc亮点

亮点风险
KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
业绩高增长
公司营业收入稳步增长,连续3年增长20.61%
业绩增长期
公司处于发展阶段,最新年度总收入33.65M美元
估值低估
公司最新PE估值-77.22,处于3年历史低位
机构减仓
最新机构持股25.43M股,环比减少0.92%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值2.15M
活跃度降低
近期活跃度降低,过去20天平均换手率-0.08

KORU Medical Systems Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

KORU Medical Systems Inc简介

KORU Medical Systems, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing patient-centric large volume subcutaneous infusion solutions primarily for the subcutaneous drug delivery market. The Company is focused on its mechanical infusion products, the FREEDOM Infusion Systems (FREEDOM System), which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. The Company’s infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
公司代码KRMD
公司KORU Medical Systems Inc
CEOTharby (Linda M)
网址https://www.korumedical.com/

常见问题

KORU Medical Systems Inc(KRMD)的当前股价是多少?

KORU Medical Systems Inc(KRMD)的当前股价是 6.230。

KORU Medical Systems Inc的股票代码是什么?

KORU Medical Systems Inc的股票代码是KRMD。

KORU Medical Systems Inc股票的52周最高点是多少?

KORU Medical Systems Inc股票的52周最高点是6.608。

KORU Medical Systems Inc股票的52周最低点是多少?

KORU Medical Systems Inc股票的52周最低点是1.860。

KORU Medical Systems Inc的市值是多少?

KORU Medical Systems Inc的市值是288.41M。

KORU Medical Systems Inc的净利润是多少?

KORU Medical Systems Inc的净利润为-6.07M。

现在KORU Medical Systems Inc(KRMD)的股票是买入、持有还是卖出?

根据分析师评级,KORU Medical Systems Inc(KRMD)的总体评级为买入,目标价格为5.650。

KORU Medical Systems Inc(KRMD)股票的每股收益(EPS TTM)是多少

KORU Medical Systems Inc(KRMD)股票的每股收益(EPS TTM)是-0.081。
KeyAI